COVID-19 Related Arterial Coagulopathy
| Autor: | Gagandeep Singh, Srimathi Manickaratnam, Khubaib Mapara, Naga Vaishnavi Gadela, Hassan Bin Attique |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease of 2019 (covid-19) Infectious Disease Disease arterial thrombosis 030204 cardiovascular system & hematology medicine.disease_cause coagulopathy Sepsis 03 medical and health sciences 0302 clinical medicine Internal medicine left ventricle (lv) thrombus ischemic stroke Coagulopathy Medicine Coronavirus business.industry General Engineering venous thromboembolism (vte) Hematology medicine.disease Thrombosis Venous thrombosis Cardiac/Thoracic/Vascular Surgery acute limb ischemia Cardiology business 030217 neurology & neurosurgery |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.9490 |
| Popis: | Coronavirus disease of 2019 (COVID-19) is a disease caused by the novel coronavirus SARS-CoV-2, which is characterized by a multitude of clinical abnormalities, including hypercoagulability. Although thrombosis is commonly observed in sepsis, the hypercoagulable state associated with COVID-19 is much more dramatic and may not be related to either the severity of the disease or the D-dimer levels. It may be due to a prothrombotic state induced by the disease itself. We report three cases of arterial thrombosis with a significant clot burden requiring urgent medical and surgical intervention. It is now a common practice to initiate anticoagulation for deep venous thrombosis (DVT) prophylaxis based on the D-dimer level in hospitalized patients with COVID-19. However, in our clinical experience, D-dimer levels did not correlate well with the clot burden or the risk for future thrombosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|